Association between lung cancer and microsomal epoxide hydrolase genotypes

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5291-5293

  Benhamou, Simone ^a   Reinikainen, Maria ^b   Bouchardy, Christine ^c   Dayer, Pierre ^d   Hirvonen, Ari ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c GENEVA CANCER REGISTRY   (Switzerland)

^d UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; EPOXIDE HYDROLASE; MICROSOME ENZYME;

ARTICLE; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXON; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; METABOLISM; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EPOXIDE HYDROLASES; EXONS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MICROSOMES; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0032401807     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Oesch, F. Mammalian epoxide hydrolases: inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica, 3: 305-340, 1973.
2. Sims, P., Grover, P. L., Swaisland, A., Pal, K., and Hewer, A. Metabolic activation of benzo(a)pyrene proceeds by a diol epoxide. Nature (Lond.), 252: 326-328, 1974.
3. Omiecinski, C. J, Aicher, L., Holubkov, R., and Checkoway, H. Human peripheral lymphocytes as indicators of human epoxide hydrolase activity in liver and lung. Pharmacogenetics, 3: 150-158, 1993.
4. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3: 421-428, 1994.
5. 1. Proc. Natl. Acad. Sci. USA, 92: 2384-2387, 1995.
6. Lancaster, J. M., Browniee, H. A., Bell, D. A., Futreal, A., Marks, J. R., Berchuck, A., Wiseman, R. W., and Taylor, J. A. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol. Carcinog., 17: 160-162, 1996.
7. Heckbert, S. R., Weiss, N. S., Hornung, S. K., Eaton, D. L., and Motulsky, A. G. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl. Cancer Inst., 84: 414-422, 1992.
8. Smith, C. A. D., and Harrison, D. J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet, 350: 630-633, 1997.
9. Bouchardy, C., Benhamou, S., and Dayer, P. The effect of tobacco on lung cancer depends on CYP2D6 activity. Cancer Res., 56: 251-253, 1996.
10. IARC. Tobacco smoking. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC Sci. Publ., 38: 55, 1986.
11. Bouchardy, C., Wikman, H., Benhamou, S., Hirvonen, A., Dayer, P., and Husgafvel-Pursiainen, K. CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers, 2: 131-134, 1997.
12. Jourenkova, N., Reinikainen, M., Bouchardy, C., Husgafvel-Pursiainen, K., Dayer, P., Benhamou, S., and Hirvonen, A. Effects of glutathione S-transferase GSTM1 and GSTT1 genotypes on lung cancer risk among smokers. Pharmacogenetics, 7: 515-518, 1997.
13. Breslow, N. E., and Day, N. E. The analysis of case-control studies. In: Statistical Methods in Cancer Research, IARC Scientific Publications Vol. 1, No. 32, pp. 192-242. Lyon, France: IARC, 1980.
14. GLIM. Numerical Algorisms Group. Royal Statistical Society. C. D. Payne (ed.), The Generalised Linear Interactive Modelling System, 2nd ed. Oxford: The Nuffield Press, 1987.